Senti Biosciences

Filed a patent for "sustained transgene expression of modified ert2 peptide-suicide protein fusion polypeptides" on Thu, February 2, 2023

Filed a patent for "inducible cell death systems and uses thereof" on Thu, February 2, 2023

Filed a patent for "antigen-binding domains and methods of use thereof" on Mon, April 17, 2023

Filed a patent for "macrophage-specific promoters and uses thereof" on Mon, April 17, 2023

Filed a patent for "modified degron polypeptides and uses thereof" on Fri, May 5, 2023

Filed a patent for "sustained transgene expression of modified ert2 peptide-suicide protein fusion polypeptides" on Fri, May 12, 2023

Filed a patent for "ert2 mutants, inducible cell death systems, and uses thereof" on Fri, May 12, 2023

Filed a patent for "macrophage-specific promoters and uses thereof" on Fri, June 2, 2023

Filed a patent for "macrophage-specific promoters and uses thereof" on Thu, October 5, 2023

Filed a patent for "antigen-binding domains and methods of use thereof" on Fri, October 13, 2023

Filed a patent for "armed chimeric receptors and methods of use thereof" on Thu, August 22, 2024

Filed a patent for "activation responsive promoters and uses thereof" on Thu, June 16, 2022

Filed a patent for "multicistronic chimeric protein expression systems" on Tue, August 2, 2022

Filed a patent for "cell-type specific regulatory elements for photoreceptors" on Fri, September 30, 2022

Filed a patent for "armed chimeric receptors and methods of use thereof" on Fri, October 7, 2022

Filed a patent for "armed chimeric receptors and methods of use thereof" on Fri, November 4, 2022

Filed a patent for "methods and compositions for cell-surface co-localization of chimeric proteins" on Mon, November 7, 2022

Filed a patent for "armed chimeric receptors and methods of use thereof" on Mon, November 7, 2022

Filed a patent for "armed chimeric receptors and methods of use thereof" on Wed, November 9, 2022

Filed a patent for "antigen-binding domains and methods of use thereof" on Wed, November 9, 2022

Filed a patent for "cell-type specific regulatory elements for photoreceptors" on Wed, November 16, 2022

Filed a patent for "multicistronic chimeric protein expression systems" on Mon, January 23, 2023

Filed a patent for "chimeric receptors and methods of use thereof" on Thu, November 23, 2023

Filed a patent for "protein payload release" on Thu, March 14, 2024

Filed a patent for "inducible cell death systems" on Thu, December 21, 2023